Insider Trading Alert - KND, ALQA And OSK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 4, 2015, 82 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1.50 to $744,000,000,054.72.

Highlighted Stocks Traded by Insiders:

Kindred Healthcare (KND) - FREE Research Report

Breier Benjamin A, who is President & CEO at Kindred Healthcare, sold 5,400 shares at $23.38 on May 4, 2015. Following this transaction, the President & CEO owned 573,850 shares meaning that the stake was reduced by 0.93% with the 5,400-share transaction.

The shares most recently traded at $23.64, up $0.26, or 1.11% since the insider transaction. Historical insider transactions for Kindred Healthcare go as follows:

  • 4-Week # shares sold: 9,810
  • 12-Week # shares sold: 10,191
  • 24-Week # shares bought: 8,000
  • 24-Week # shares sold: 10,191

The average volume for Kindred Healthcare has been 1.2 million shares per day over the past 30 days. Kindred Healthcare has a market cap of $2.0 billion and is part of the health care sector and health services industry. Shares are up 33% year-to-date as of the close of trading on Monday.

Kindred Healthcare, Inc. provides healthcare services in the United States. It operates in four divisions: Hospital, Nursing Center, Rehabilitation, and Care Management. The stock currently has a dividend yield of 1.99%. Currently, there are 3 analysts who rate Kindred Healthcare a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KND - FREE

TheStreet Quant Ratings rates Kindred Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, generally higher debt management risk and poor profit margins. Get the full Kindred Healthcare Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues

Kindred Sells Skilled Nursing Facility Business for $700M

13 Things Kentucky Is Best Known for Other Than the Kentucky Derby

Kindred Healthcare to Explore Sale

Bullish and Bearish Reversals in the Market